Goodluck India: Defence Facility in Validation Phase
GOODLUCK Goodluck India (NSE : GOODLUCK) makes precision pipes, auto tubes, engineering structures, forgings and industrial components. Its subsidiary Goodluck Defence and Aerospace manufactures artillery shells at a plant in Sikandrabad, Uttar Pradesh, inaugurated in October 2025 under the Indian Arms Act, 1959. What happened: In Q2 FY27, total operating income grew 37.5% year on year to Rs 1,362.8 crore. EBITDA rose 30.1% to Rs 127.5 crore, at a 9.3% margin. Net profit grew 18.8% to Rs 50.7 crore. The artillery unit was in a validation phase in H1 FY27, with commercial revenue recognition expected in H2 FY27. A Rs 52.2 crore order for 20,000 shells was delivered in Q1 FY27. Why it matters: Total investment in the defence facility is Rs 500 crore, with defence capex exceeding Rs 300 crore. Capacity starts at 150,000 shells per year and can reach 400,000 within 12 to 15 months. Management targets 30%-35% EBITDA margins for the artillery vertical and Rs 300 crore in defence revenue for FY27. Recognition depends on inspection, ballistic validation and export clearance. What I am watching: Whether commercial revenue begins in H2 FY27 as guided. The company holds Rs 350 crore in defence orders but announces awards only after advance payments, so actual commitments may exceed what is disclosed. Management also guides for 15%-20% consolidated revenue growth in FY27, with EBITDA margin of 10%-12%. My stance: Goodluck India trades at 25.9 times earnings, above its five-year median of 21.2 times and the industry median of 20.4 times. ROCE is 14.4% and ROE is 13.0%. The premium over historical median prices in defence revenue that remains unrecognised commercially. I do not hold a position in Goodluck India at the time of writing. This is not investment advice.



















